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Consumption of regular-fat vs reduced-fat
cheese reveals gender-specific changes in
LDL particle size - a randomized controlled
trial
Farinaz Raziani1, Parvaneh Ebrahimi2*, Søren Balling Engelsen2, Arne Astrup1, Anne Raben1 and Tine Tholstrup1
Abstract
Background: Regular-fat cheese does not seem to increase low density lipoprotein cholesterol (LDL-C) concentrations
compared to reduced-fat cheese. However, plasma LDL-C concentrations do not reflect levels and size of LDL particles,
which might be a better predictor of cardiovascular risk.
Methods: The aim was to compare the effects of regular-fat cheese vs reduced-fat cheese and carbohydrate-rich foods
on LDL particle size distribution in adults with ≥ 2 metabolic syndrome (MetS) risk factors. The study was part of a 12
weeks’ randomized controlled trial in which subjects had been randomly allocated to 1 of 3 intervention groups;
regular-fat cheese (REG), reduced-fat cheese (RED) or a no-cheese/carbohydrate (CHO) group. Subjects in the REG and
RED groups consumed 80 g cheese/d per 10 MJ, whereas subjects in the CHO consumed bread and jam
corresponding to 90 g/d and 25 g/d per 10 MJ, respectively. Fasting blood samples at wk. 0 (baseline) and wk. 12 were
analyzed for LDL particle size distribution and cholesterol content using nuclear magnetic resonance (NMR)
spectroscopy.
Results: A total of 85 subjects [mean ± SD age: 54.0 ± 12.8 y; BMI: 28.7 ± 3.6 kg/m2] completed the study. Overall,
regular-fat cheese did not impact lipoprotein particle number and size differently than reduced-fat cheese. In men (n =
23), the REG diet decreased total LDL particle number (LDL-P, − 223.2 ± 91.1 nmol/l, P = 0.01) compared with the RED
diet. The reduction was primarily in the medium-sized LDL fraction (− 128.5 ± 51.8 nmol/l, P = 0.01). In women (n = 62),
the REG diet increased the concentration of cholesterol in the small high density lipoprotein (HDL) particles compared
with the CHO diet (2.9 ± 1.0 mg/dl, P = 0.006).
Conclusion: Overall, regular-fat cheese did not alter LDL particle size distribution compared to reduced-fat cheese after
a 12 wk. intervention in subjects with ≥2 MetS risk factors. However, our results suggest that lipoprotein response to
cheese intake is gender-specific. This warrants further investigation.
Trial registration: This trial was registered at Clinicaltrials.gov as NCT0261471. Registered 30 November 2015 -
Retrospectively registered.
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Background
Epidemiological studies have revealed that reducing
plasma cholesterol levels results in clinically relevant re-
ductions in risk factors for cardiovascular disease (CVD)
[1]. Although increased plasma low density lipoprotein
cholesterol (LDL-C) concentrations is considered one of
the main CVD risk factors, a number of individuals who
develop atherosclerosis and CVD have LDL-C concen-
trations in the normal range [2]. The main reason for
this observation is that LDL particles are heterogeneous
in respect to size, density, and physiochemical properties
[3]. In the case of LDL, the concentration of LDL-C does
not reflect the levels of LDL particle size. Studies show
that a higher presence of small, dense LDL (sdLDL) par-
ticles is associated with a higher risk of CVD [4, 5], inde-
pendent of plasma LDL-C concentrations [6, 7].
The main focus of dietary recommendations for CVD
prevention and management has been a reduction of diet-
ary fat, in particular saturated fatty acids [8]. Interestingly,
Dreon et al. found a positive correlation between SFA
intake and large, buoyant LDL particles, with no such
association with poly- or mono-unsaturated fatty acids [9].
Another study found that substituting saturated fat with
carbohydrates resulted in smaller and denser LDL particles
[10]. Thus, the benefit of reducing the intake of foods with
high amounts of saturated fat is highly dependent on what
is eaten instead.
Cheese is a dairy product with a high content of satu-
rated fat. Therefore, it is a common perception that
cheese increases plasma LDL-C and in turn CVD risk.
However, human intervention studies show that cheese
has a neutral effect on plasma cholesterol levels when
compared with butter intake [11]. Likewise, prospective
studies found no association between cheese intake and
CVD risk [12, 13] or increased risk of all-cause mortality
[14]. One of the explanations behind the findings from
prospective studies might be that saturated fat in cheese
results in larger LDL particle size. This has, however not
yet been confirmed in a clinical trial.
The primary objective of the current study was to com-
pare the effect of cheese intake with different fat content
and an iso-caloric amount of carbohydrate-rich foods on
LDL particle size distribution in a metabolically vulnerable
study population. Based on studies showing that the in-
crease in LDL-C induced by saturated fat results in a higher
proportion of larger and less atherogenic LDL particles
[15–18], we hypothesized that intake of regular-fat cheese
would be associated with larger LDL particles compared to
reduced-fat cheese and a carbohydrate-rich control diet.
Methods
Study design
The present study was part of a larger study, which has
been described in detail elsewhere [19]. In brief, 164
subjects (18–70 years of age) were recruited for a 12-wk
randomized, parallel intervention, with a 2-wk run-in
period. Subjects were allocated to three intervention
groups; regular-fat cheese (REG), reduced-fat cheese
(RED), or non-cheese/carbohydrate (CHO). Fasting
blood samples were drawn after the 2-wk run-in period
at baseline (wk 0) and after the 12-wk intervention
period. The study was carried out at the Department of
Nutrition, Exercise and Sports, Faculty of Sciences,
University of Copenhagen, Frederiksberg, Denmark,
from February 2014 to May 2015 and was approved by
the Municipal Ethical Committee of Copenhagen
(H-4-2013-099). All of the subjects gave their informed
consent in writing after receiving written and oral infor-
mation about the study.
Subjects
In this sub-study, EDTA plasma was collected at wk. 0
and wk. 12 from the 164 subjects included in the main
intervention. However, due to technical issues, only
blood samples collected from 85 subjects were stored
properly and could be used for analysis in this
sub-study.
Inclusion criteria were 18–70 y of age, BMI (in kg/m2)
of 18.5–37.5, waist circumference > 80 cm for women
and > 94 cm for men, and ≥ 1 additional established risk
factor for the MetS; systolic blood pressure > 130 mmHg
and/or diastolic blood pressure > 85 mmHg, triacylglyc-
erols > 1.7 mmol/l, HDL cholesterol < 1.00 mmol/l for
men and < 1.3 mmol/l for women, and/or glucose >
5.6 mmol/l. Exclusion criteria were chronic diseases
(known T2D, CVD, or other chronic diseases that could
affect the study outcome), milk allergy, the use of pre-
scription medicine that could affect the results of the
study (e.g., lipid-lowering agents), 10 h of strenuous
physical activity/wk., drug and alcohol abuse, blooddona-
tion,1 mo before study commencement or during the
study period, simultaneous participation in other clinical
studies, pregnant or lactating woman or women who
were planning to become pregnant during the interven-
tion, or inability to comply with the procedures required
by the protocol.
Subjects (62 women and 23 men) with ≥2 metabolic
syndrome risk factors had a mean BMI of 28.7 ± 3.6 kg/
m2 and a mean age of 54.0 ± 12.8 y. Baseline characteris-
tics of the 85 subjects included in this study are listed in
Table 1.
Experimental diets
The energy content and macronutrient distribution of
the three test foods have been described in detail else-
where [19]. In short, subjects in the REG and RED
groups were provided with equal amounts of regular-fat
Danbo (Riberhus, 25% fat, Arla, Denmark) and cheddar
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(Sharp Cheddar, 32% fat, Lactalis, Scotland), and
reduced-fat Danbo (Riberhus,13% fat, Arla, Denmark)
and cheddar (Sharp Cheddar, 16% fat, Lactalis,
Scotland), respectively. In the CHO group, cheese was
replaced with white wheat bread (Kohberg, Denmark)
and sugar-sweetened jam (Fynbo, Denmark). Subjects in
all three groups were also provided with 250 ml of
skimmed milk (0.1% fat, Arla, Denmark) per day
throughout the intervention. No other dairy products
were allowed during the intervention. The daily amounts
of cheese provided corresponded to 80 g/d per 10 MJ,
while the daily amounts of bread and jam corresponding
to 90 g/d and 25 g/d per 10 MJ, respectively.
Dietary records
In order to provide information about dietary intake
during the intervention, subjects completed a 3-d dietary
food records at wk. 0 and wk. 12. Two week-days and
one weekend day were included in the dietary record to
take any differences in nutrient intake during weekdays
and weekend days into account.
Analytic procedures
1H NMR lipoprotein subclass analysis
Serum samples, stored in EDTA containing tubes, were
prepared and measured according to Bruker’s sample
preparation standard operating procedures (SOPs) and
In Vitro Diagnostics research (IVDr) platform, which
allow highly standardized and reproducible NMR mea-
surements of biofluids, as reported previously [20]. The
spectrometer was a Bruker Avance-III 600 spectrometer
(Bruker Biospin Gmbh, Rheinstetten, Germany) operat-
ing at a proton frequency of 600.13 MHz (14.1 T),
equipped with a double tuned broadband inverse (BBI)
probe for 5-mm sample tubes. Bruker IVDr Lipoprotein
Subclass Analysis (B.I.-LISA) was then used to analyze
the resulted 1H NMR spectra and calculate lipoproteins
subclasses. In brief, this platform uses a regression
model that is developed using ultracentrifugation results
of a training dataset, which allows for prediction of the
concentrations of the lipoproteins from the 1H NMR
spectra of new plasma samples without any further need
for ultra-centrifugation [21, 22]. This model provides
information on main lipoprotein classes, including very
low density lipoprotein (VLDL), intermediate density
lipoprotein (IDL), LDL, and high density lipoprotein
(HDL), as well as the six VLDL subclasses (VLDL-1 to
VLDL-6), six LDL subclasses (LDL-1 to LDL-6), and
four HDL subclasses (HDL-1 to HDL-4). Subclasses
were sorted according to their increasing density and de-
creasing size in ascending order, respectively. Compos-
itional information of main –and subclasses consists of
lipids, i.e., cholesterol, free cholesterol, triglycerides,
phospholipids and apolipoproteins; Apo-A1, Apo-A2
and Apo-B in mg/dl unit. Moreover, information on par-
ticle numbers for VLDL, IDL and LDL main classes, and
VLDL and LDL subclasses were also obtained from
B.I.-LISA, in nmol/L unit.
Statistical analysis
All statistical analyses were performed using R (R Core
Team, 2015) [23]. Linear mixed models were used to
evaluate the effect of the intervention on all outcomes.
Baseline outcome values were included as covariates.
Adjustments for age, sex, BMI, and changes in body fat
percent (from wk. 0 to wk. 12) were also included as
fixed effects. As a significant effect of sex was observed,
separate sub-analysis for men and women were carried
out for all outcomes. Differences between periods were
captured by means of random effects. For each outcome
two pairwise comparisons were evaluated: REG versus
RED and REG versus CHO, using post hoc t-test based
on the linear mixed models; p-values were adjusted for
multiplicity [24]. Model checking of assumptions of
Table 1 Subject baseline characteristicsa
REG (n = 30) RED (n = 26) CHO (n = 29)
Sex [n (%)]
Women 21(70) 21 (81) 20 (69)
Men 9 (30) 5 (19) 9 (31)
Age (y) 54.8 ± 13.7 51.8 ± 13.4 55.0 ± 11.6
Weight (kg) 84.2 ± 14.3 84.5 ± 11.2 84.3 ± 16.5
BMI (kg/m2) 29.3 ± 3.6 28.4 ± 3.0 28.4 ± 4.0
Waist circumference (cm) 98.1 ± 11.6 96.7 ± 10.3 96.9 ± 10.9
Smoking [n (%)] 1 (3) 2 (7) 1 (3)
Energy requirement (MJ/d) 10.3 ± 1.9 10.3 ± 1.8 10.2
Systolic blood pressure (mmHG) 133.2 ± 16.3 129.7 ± 14.1 128.0 ± 16.8
Diastolic blood pressure (mmHG) 85.7 ± 9.1 82.8 ± 8.6 84.0 ± 8.3
aValues are means ± SDs unless otherwise indicated. n = 85. CHO carbohydrate control, RED reduced-fat cheese, REG regular-fat cheese
Raziani et al. Nutrition & Metabolism  (2018) 15:61 Page 3 of 10
homogeneity of variance and normal distribution was
carried out by means of residual and normal probability
plots. Results are presented as means ± SEMs. A signifi-
cance level of 0.05 was used.
Results
Anthropometrics
Changes in mean anthropometric measures, body com-
position, and blood pressure are shown in Table 2. There
were no significant differences in body weight, fat mass,
lean body mass, waist circumference, or blood pressure
between REG and RED diets or between the REG and
CHO diets (all P ≥ 0.05).
Lipoprotein particle number
Changes from baseline as well as differences between
groups for total VLDL-P and its subclasses, IDL-P,
and LDL-P and its subclasses are shown in Table 3.
Overall, there were no significant differences for these
outcomes between the REG diet and RED diet or
between REG and CHO diet (all P ≥ 0.16). The gender
sub analysis showed similar results in women (all P ≥
0.17), (Table 4). However, the gender sub analysis
showed a decrease in LDL-P in men on the REG diet
compared to the RED diet (− 223.2 ± 91.1 nmol/l, P =
0.01) (Table 5). The decrease in LDL-P in men was
primarily due to a lower number of medium-sized
LDL particles (− 128.5 ± 51.8 nmol/l, P = 0.01). Ratios
of LDL-C:HDL-C and ApoB:ApoA-1 were significantly
reduced in men on the REG diet compared with the
RED diet (− 0.53 ± 0.13, P = 0.0007 and 0.09 ± 0.03, P
= 0.009, respectively), but did not differ from that of
the CHO diet (Table 5).
Cholesterol concentration in lipoprotein subclasses
Total VLDL-C and LDL-C did not differ between the
diets (all P ≥ 0.2) (Table 3). However, the gender sub ana-
lysis in men showed a reduction of total LDL-C (− 19.4
± 9.5 mg/dl, P = 0.04). The decrease in total LDL-C in
men was due to a decreased concentration of cholesterol
in the medium-sized (LDL3 + 4) and small-sized (LDL5 +
6) LDL particles in the REG diet compared to the RED
diet (− 11.3 ± 5.2 mg/dl, P = 0.03 and − 10.1 ± 5.0 mg/dl,
P = 0.04, respectively) (Table 5). Total HDL-C was higher
on the REG diet compared with the CHO diet (3.5 ±
1.6 mg/dl, P = 0.03) (Table 3). The increase in total
HDL-C was due to a significantly higher concentration
of cholesterol in the smaller HDL particles (HDL3 + 4) on
the REG diet compared with the CHO diet (1.9 ±
0.8 mg/dl, P = 0.02). The gender sub analysis in women
showed similar results with an increase in total HDL-C
and cholesterol in the smaller HDL particles (HDL3 + 4)
on the REG diet compared to the CHO diet (4.8 ±
2.1 mg/dl, P = 0.02 and 2.9 ± 1.0 mg/dl, P = 0.006,
respectively) (Table 4). In contrast, the gender sub ana-
lysis in men showed no differences in HDL-C between
the diets (Table 5).
Dietary records
Results from the dietary records are shown in Table 6.
Energy intake did not differ between groups, although
subjects in the REG group tended to have a higher en-
ergy intake compared with the CHO group (P = 0.08).
Fat intake (in g and percentage of energy) was higher
during the REG intervention than during the CHO (P <
0.001) diets, but did not differ between the REG and
RED diets. There was a higher intake of saturated fat
during the REG diet compared to the RED and CHO
Table 2 Fasting values of anthropometric measurements, body composition and blood pressure at week 12 and changes from
baselinea
REG (n = 30) RED (n = 26) CHO (n = 29) REG vs. RED REG vs. CHO
Week 12 Change from
baseline
Week 12 Change from
baseline
Week 12 Change from
baseline
P P
Body weight (kg) 84.6 ± 2.7 0.4 ± 0.3 85.1 ± 2.4 0.6 ± 0.3 84.5 ± 3.3 0.2 ± 0.3 0.39 0.91
WC (cm) 98.7 ± 2.0 0.5 ± 0.4 98.4 ± 2.0 1.1 ± 0.5 96.9 ± 2.3 0.0 ± 0.6 0.52 0.46
BMI (kg/m2) 29.5 ± 0.7 0.1 ± 0.1 28.8 ± 0.6 0.2 ± 0.1 28.5 ± 0.8 0.1 ± 0.1 0.61 0.89
Fat Mass (kg) 32.2 ± 1.6 0.0 ± 0.2 34.6 ± 1.4 0.7 ± 0.3 32.1 ± 1.9 − 0.3 ± 0.3 0.09 0.71
Fat percent (%) 38.1 ± 1.3 − 0.2 ± 0.2 40.6 ± 1.2 0.4 ± 0.3 38.0 ± 1.6 − 0.2 ± 0.3 0.17 0.88
Lean Body Mass
(kg)
49.2 ± 1.9 0.3 ± 0.2 47.2 ± 1.7 0.0 ± 0.3 48.9 ± 2.3 0.1 ± 0.3 0.65 0.54
Systolic BP
(mmHg)
132.3 ± 2.5 − 1.0 ± 2.0 126.0 ± 2.0 −4.0 ± 1.7 126.6 ± 2.4 − 1.4 ± 2.2 0.09 0.14
Diastolic BP
(mmHg)
83.9 ± 1.6 − 1.8 ± 0.9 80.4 ± 1.7 − 2.3 ± 1.1 81.7 ± 1.3 − 2.2 ± 1.0 0.35 0.48
aAll values are means ± SEMs. Significant differences between groups are based on linear mixed models with baseline values as covariates and adjustments for
age, sex, BMI, and change in body fat. Pairwise comparisons were made by using a post hoc t test on the linear mixed model with P values adjusted for
multiplicity. BP blood pressure, CHO carbohydrate control, RED reduced-fat cheese, REG regular-fat cheese, WC waist circumference
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diets (P < 0.01 and P < 0.001, respectively). The amount
of MUFAs was significantly higher with the REG diet
than with the CHO diet (P < 0.01). As expected, the in-
take of carbohydrate was greater with the CHO diet than
with the REG diet (P < 0.001).
Discussion
In the present study, we compared the effects of con-
suming regular-fat cheese, reduced-fat cheese and
carbohydrate-rich foods for 12 wks on lipoprotein par-
ticle size distribution in a population with ≥2 metabolic
syndrome (MetS) risk factors. Our results demonstrated
that long-term consumption of regular-fat cheese did
not modify the distribution of LDL subclasses differently
compared with reduced-fat cheese. The lack of differ-
ences in LDL particle size between the two cheese
groups were unexpected, as the saturated fat intake in
the regular-fat cheese group was significantly higher
than in the reduced-fat cheese group (33.3 g/d vs.
27.2 g/d). However, it can be speculated that the differ-
ences in saturated fat were insufficient to elicit a signifi-
cant shift towards larger LDL particles in the regular-fat
cheese group, as overall fat intake did not differ between
the two groups. Furthermore, it cannot be ruled out that
the effect of fat in cheese on LDL particle size might be
modulated by constituents in the cheese matrix. The
high content of calcium in cheese has been suggested to
modulate the effect of saturated fat on LDL-C
Table 3 Lipoprotein particle number and cholesterol content at wk. 12 and changes from baseline in men and womena
REG (n = 30) RED (n = 26) CHO (n = 29) REG vs.
RED
REG vs.
CHO
Week 12 Change from
baseline
Week 12 Change from
baseline
Week 12 Change from
baseline
P P
VLDL-P (nmol/l)2 148.4 ± 14.1 − 3.6 ± 15.3 129.5 ± 9.4 −6.0 ± 8.8 126.1 ± 13.8 3.4 ± 6.7 0.56 0.67
IDL-P (nmol/L) 73.3 ± 6.9 − 4.5 ± 6.9 68.5 ± 6.5 − 6.1 ± 5.0 68.2 ± 7.0 2.1 ± 4.3 0.62 0.81
LDL-P (nmol/l)
Total 1322 ± 60.0 26.2 ± 41.3 1265 ± 78.8 7.9 ± 50.2 1363 ± 55.5 − 2.9 ± 39.1 0.43 0.99
LDL1 + 2
b 415.9 ± 21.4 22.2 ± 15.1 444.2 ± 23.0 − 13.3 ± 19.3 453.2 ± 22.4 −29.3 ± 14.7 0.82 0.16
LDL3 + 4
b 403.2 ± 20.6 9.9 ± 22.4 414.9 ± 31.6 15.9 ± 19.5 403.3 ± 22.2 − 10.8 ± 18.1 0.98 0.76
LDL5 + 6
b 487.7 ± 43.1 − 12.7 ± 20.5 391.1 ± 43.6 −7.7 ± 25.7 479.6 ± 49.3 32.0 ± 19.0 0.39 0.35
VLDL-C (mg/dl)
Totalb 16.5 ± 2.2 −0.5 ± 2.4 13.2 ± 1.6 −1.3 ± 1.3 12.8 ± 2.4 0.7 ± 1.2 0.47 0.68
VLDL1 + 2 7.3 ± 1.2 0.7 ± 1.1 4.9 ± 0.9 − 0.5 ± 0.6 5.0 ± 1.3 0.1 ± 0.1 0.26 0.56
VLDL3 + 4
b 6.7 ± 1.0 − 1.2 ± 1.3 5.6 ± 0.7 −1.0 ± 0.7 5.4 ± 1.0 − 0.2 ± 0.5 0.67 0.87
VLDL5 + 6
b 2.1 ± 0.1 − 0.1 ± 0.1 2.0 ± 0.1 0.0 ± 0.1 2.0 ± 0.1 0.7 ± 0.7 0.96 0.68
IDL-C (mg/dl) 7.0 ± 1.1 − 0.2 ± 0.9 6.7 ± 1.1 −1.5 ± 1.3 7.1 ± 1.3 0.1 ± 0.7 0.28 0.81
LDL-C (mg/dl)
Total 118.2 ± 5.4 3.7 ± 4.4 117.3 ± 7.3 3.8 ± 4.9 122.6 ± 4.5 −2.6 ± 3.9 0.69 0.70
LDL1 + 2
b 42.8 ± 2.5 2.7 ± 1.7 46.6 ± 2.6 −0.5 ± 2.3 47.2 ± 2.4 −3.2 ± 1.9 0.51 0.19
LDL3 + 4
b 38.2 ± 2.2 0.9 ± 2.1 40.0 ± 3.1 2.3 ± 2.1 38.7 ± 2.2 −1.7 ± 1.8 0.72 0.57
LDL5 + 6
b 36.2 ± 3.1 − 0.5 ± 1.4 29.6 ± 3.4 0.2 ± 2.0 35.7 ± 3.5 2.1 ± 1.5 0.88 0.21
HDL-C (mg/dl)
Total 56.0 ± 2.9 2.2 ± 1.0 56.5 ± 2.5 2.4 ± 1.3 55.9 ± 2.3 − 0.6 ± 1.3 0.84 0.03
HDL1 + 2
b 27.1 ± 2.7 1.0 ± 0.8 27.5 ± 2.1 0.6 ± 1.0 28.6 ± 2.0 0.1 ± 1.1 0.68 0.23
HDL3 + 4
b 29.4 ± 0.8 1.2 ± 0.6 29.4 ± 0.9 1.6 ± 0.7 27.8 ± 0.9 − 0.8 ± 0.6 0.95 0.02
LDL-C:HDL-C
ratio
2.2 ± 0.1 0.0 ± 0.1 2.2 ± 0.2 0.0 ± 0.1 2.3 ± 0.1 0.0 ± 0.1 0.62 0.81
Apo-B:Apo-A1
ratio
0.6 ± 0.0 0.0 ± 0.0 0.6 ± 0.0 0.0 ± 0.1 0.7 ± 0.0 0.0 ± 0.0 0.67 0.16
aAll values are means ± SEMs. Statistical differences between groups are based on linear mixed models with baseline values as covariates and adjustments for
age, sex, BMI and change in body fat. Pairwise comparisons were made using post hoc t-test on the linear mixed model with p-values adjusted for multiplicity.
bSignificant sex effect observed. Abbreviations: Apo apolipoprotein, CHO carbohydrate control, HDL-C high density lipoprotein cholesterol, IDL-C intermediate
density lipoprotein cholesterol, IDL-P intermediate density lipoprotein particle number, LDL-C low density lipoprotein cholesterol, LDL-P low density lipoprotein
particle number, RED reduced-fat cheese, REG regular-fat cheese, VLDL-C very low density lipoprotein cholesterol, VLDL-P very low density lipoprotein
particle number
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concentrations by increasing fecal fat excretion. Mea-
surements of fecal fat and energy excretion in this study
could have added to the mechanistic understanding of
the observed findings. Our finding is in accordance with
a recently published study showing that despite a 6%
higher saturated fat content in a high-fat dairy DASH
diet compared with a low-fat dairy DASH diet, no differ-
ences in LDL cholesterol or any of the LDL subclasses
was observed in a population of both men and women
[25]. In the present study, however, significant
gender-specific differences in regard to LDL subfractions
were observed. In men, total LDL particle number was
significantly reduced following the REG diet compared
with the RED diet. The decrease in total LDL particle
number was primarily due to a ~ 6% lower proportion of
midsize LDL particles, while the proportion of smaller
LDL particles only tended to be reduced (P = 0.06). In
contrast to the results obtained in men, the REG diet
only tended to increase total LDL-P compared with the
RED diet in women (P = 0.08). Our findings indicate that
middle-aged men might have a more favorable lipopro-
tein response to regular-fat cheese compared to
reduced-fat cheese than middle-aged/postmenopausal
women, although this needs to be verified in further
studies with larger sample size. However, LDL particle
size distribution depends on other factors than gender
and genetics alone, including, hormonal status (at meno-
pause, LDL particle size distribution shift towards
sdLDL) [26], overall lifestyle, and dietary habits. These
factors can be difficult to adjust for in a study with “free
living” individuals. Thus, it cannot be ruled out that the
gender differences in response to the test foods in the
Table 4 Lipoprotein particle number and cholesterol content at wk. 12 and changes from baseline in womena
RED (n = 21) RED (n = 21) CHO (n = 20) REG vs. RED REG vs. CHO
Week 12 Change from
baseline
Week 12 Change from
baseline
Week 12 Change from
baseline
P P
VLDL-P (nmol/l) 135.6 ± 13.5 − 11.2 ± 20.0 126.7 ± 10.6 − 10.4 ± 10.3 104.4 ± 13.3 − 6.4 ± 7.0 0.59 0.25
IDL-P (nmol/L) 68.8 ± 6.1 −4.9 ± 9.3 68.5 ± 6.8 − 7.6 ± 5.7 63.7 ± 7.2 1.3 ± 5.5 0.75 0.91
LDL-P (nmol/l)
Total 1343.0 ± 57.4 72.4 ± 53.1 1238.3 ± 81.0 − 30.9 ± 49.4 1359.7 ± 71.9 11.3 ± 52.7 0.08 0.83
LDL1 + 2 449.9 ± 24.1 31.0 ± 19.6 459.9 ± 25.0 −14.2 ± 23.0 497.4 ± 23.5 − 22.3 ± 21.0 0.41 0.68
LDL3 + 4 471.6 ± 19.2 45.2 ± 25.5 408.4 ± 35.1 − 0.5 ± 17.7 422.8 ± 26.2 1.2 ± 24.1 0.24 0.51
LDL5 + 6 451.8 ± 42.6 −9.1 ± 25.9 354.5 ± 37.7 31.4 ± 23.6 407.7 ± 47.3 25.2 ± 18.8 0.17 0.25
VLDL-C (mg/dl)
Total 13.8 ± 2.0 −1.9 ± 3.0 12.7 ± 1.8 −2.0 ± 1.6 9.1 ± 2.1 − 0.9 ± 1.2 0.65 0.30
VLDL1 + 2 5.8 ± 1.2 0.1 ± 1.2 4.5 ± 1.0 − 0.8 ± 0.8 2.9 ± 1.1 −0.4 ± 0.6 0.31 0.21
VLDL3 + 4 5.6 ± 0.8 − 1.8 ± 1.7 5.6 ± 0.9 − 1.3 ± 0.9 4.1 ± 0.9 − 0.7 ± 0.5 0.94 0.51
VLDL5 + 6 2.0 ± 0.1 − 0.1 ± 0.2 2.1 ± 0.1 0.0 ± 0.1 1.8 ± 0.1 0.0 ± 0.1 0.62 0.83
IDL-C (mg/dl) 5.9 ± 0.9 −0.6 ± 1.1 7.3 ± 1.3 − 1.6 ± 1.6 6.1 ± 1.2 − 0.2 ± 0.8 0.83 0.60
LDL-C (mg/dl)
Total 121.3 ± 5.7 8.3 ± 5.5 114.9 ± 7.9 0.4 ± 4.8 124.6 ± 6.0 −0.3 ± 5.2 0.21 0.79
LDL1 + 2 46.4 ± 2.9 3.4 ± 2.2 48.2 ± 2.8 −0.6 ± 2.7 51.9 ± 2.5 −2.3 ± 2.2 0.60 0.74
LDL3 + 4 40.0 ± 2.2 3.9 ± 2.3 39.4 ± 3.4 0.8 ± 1.9 40.9 ± 2.6 − 0.4 ± 2.4 0.37 0.53
LDL5 + 6 33.7 ± 3.2 −0.2 ± 1.7 26.6 ± 3.0 −1.7 ± 1.7 30.7 ± 3.5 2.0 ± 1.5 0.19 0.29
HDL-C (mg/dl)
Total 61.2 ± 3.2 2.8 ± 1.2 57.9 ± 2.8 2.7 ± 1.4 59.2 ± 2.8 −1.3 ± 1.8 0.73 0.02
HDL1 + 2 31.7 ± 3.1 1.1 ± 1.0 28.9 ± 2.4 0.9 ± 1.1 32.1 ± 2.4 −0.3 ± 1.5 0.77 0.21
HDL3 + 4 30.1 ± 1.0 1.6 ± 0.8 29.3 ± 1.0 1.6 ± 0.7 27.7 ± 1.0 −1.2 ± 0.7 0.63 0.006
LDL-C:HDL-C
ratio
2.1 ± 0.1 0.1 ± 0.1 2.1 ± 0.2 −0.1 ± 0.1 2.2 ± 0.1 0.1 ± 0.1 0.20 0.69
Apo-B:Apo-A1
ratio
0.6 ± 0.0 0.0 ± 0.0 0.6 ± 0.0 0.0 ± 0.0 0.6 ± 0.0 0.0 ± 0.0 0.23 0.19
aAll values are means ± SEMs. Statistical differences between groups are based on linear mixed models with baseline values as covariates and adjustments for
age, BMI and change in body fat. Pairwise comparisons were made using post hoc t-test on the linear mixed model with p-values adjusted for multiplicity.
Abbreviations: Apo apolipoprotein, CHO carbohydrate control, HDL-C high density lipoprotein cholesterol, IDL-C intermediate density lipoprotein cholesterol, IDL-P
intermediate density lipoprotein particle number, LDL-C low density lipoprotein cholesterol, LDL-P low density lipoprotein particle number, RED reduced-fat
cheese, REG regular-fat cheese, VLDL-C very low density lipoprotein cholesterol, VLDL-P very low density lipoprotein particle number
Raziani et al. Nutrition & Metabolism  (2018) 15:61 Page 6 of 10
current study have been influenced by these additional
factors.
The saturated fat in regular-fat cheese did not result in
larger LDL particles compared to the carbohydrate con-
trol, despite the significantly higher intake of saturated
fat (33.3 g/d vs. 19.0 g/d). This was unexpected, as indi-
viduals who consume diets high in saturated fat appear
to have larger LDL particles compared with diets high in
carbohydrates [9, 10]. However, most of these studies
were conducted in normolipidemic men and not in a
population of men and women with risk factors for the
MetS as in the current study. Also, these studies are
often carried out with carbohydrate restriction in the
high-fat groups. However, the fact that subjects in this
study were not carbohydrate-restricted in the regular-fat
cheese group might explain the lack of difference.
The present study confirmed previous observations that
diets with higher fat content increases HDL-C compared
to carbohydrate-rich diets [27]. Overall, the concentration
of total HDL-C was significantly higher for the regular-fat
cheese diet compared with the carbohydrate-rich diet.
The increase in total HDL-C was due to a higher concen-
tration of cholesterol carried in the smaller HDL sub-
classes. Interestingly, a gender sub analysis revealed that
these differences in HDL-C were only true for women.
However, as this study did not have results on HDL par-
ticle size distribution, the study cannot confirm if changes
in HDL-C concentrations in women were due to changes
Table 5 Lipoprotein particle number and cholesterol content at wk. 12 and changes from baseline in mena
REG (n = 9) RED (n = 5) CHO (n = 9) REG vs.
RED
REG vs.
CHO
Week 12 Change from
baseline
Week 12 Change from
baseline
Week 12 Change from
baseline
P P
VLDL-P (nmol/
l)
178.3 ± 34.0 14.3 ± 21.1 141.3 ± 21.7 12.5 ± 14.8 174.5 ± 28.2 25.2 ± 13.0 0.56 0.12
IDL-P (nmol/L) 83.9 ± 18.5 −3.4 ± 8.2 68.2 ± 19.7 0.1 ± 10.9 78.0 ± 16.0 3.8 ± 7.2 0.61 0.24
LDL-P (nmol/l)
Total 1275.3 ± 154.4 −81.7 ± 45.5 1381.7 ± 244.9 171.0 ± 150.1 1372.0 ± 86.3 −34.6 ± 48.5 0.01 0.68
LDL1 + 2 336.4 ± 31.8 1.6 ± 21.3 378.1 ± 51.9 −9.6 ± 31.3 355.0 ± 31.3 −44.8 ± 8.6 0.45 0.05
LDL3 + 4 369.5 ± 53.0 −72.4 ± 32.2 441.8 ± 79.5 84.5 ± 65.9 359.9 ± 40.3 −37.3 ± 21.8 0.01 0.53
LDL5 + 6 571.4 ± 103.3 −21.1 ± 33.9 544.8 ± 156.7 91.8 ± 81.7 639.2 ± 104.8 47.1 ± 46.2 0.06 0.12
VLDL-C (mg/dl)
Total 22.7 ± 5.4 2.7 ± 4.1 15.1 ± 3.4 1.5 ± 1.7 21.0 ± 5.1 4.1 ± 2.7 0.97 0.22
VLDL1 + 2 10.6 ± 2.6 1.9 ± 2.5 6.7 ± 2.1 0.9 ± 1.0 9.6 ± 2.9 3.0 ± 1.6 0.79 0.28
VLDL3 + 4 9.3 ± 2.7 0.3 ± 1.6 5.7 ± 1.4 0.4 ± 1.4 8.3 ± 2.4 1.1 ± 1.2 0.67 0.19
VLDL5 + 6 2.2 ± 0.4 0.1 ± 0.2 1.8 ± 0.1 0.0 ± 0.3 2.4 ± 0.3 0.1 ± 0.2 0.76 0.72
IDL-C (mg/dl) 9.6 ± 3.0 0.7 ± 1.6 4.3 ± 1.5 −1.3 ± 2.3 9.4 ± 3.2 0.8 ± 1.5 0.69 0.55
LDL-C (mg/dl)
Total 111.0 ± 12.8 −6.9 ± 5.8 127.1 ± 20.1 18.2 ± 15.7 118.3 ± 6.1 −7.8 ± 5.1 0.04 0.82
LDL1 + 2 34.3 ± 3.5 1.0 ± 2.5 40.1 ± 6.0 0.0 ± 4.0 36.8 ± 3.5 −5.1 ± 1.2 0.88 0.03
LDL3 + 4 33.9 ± 5.1 −6.2 ± 3.5 42.5 ± 7.5 8.4 ± 7.2 33.7 ± 4.1 −4.5 ± 2.3 0.03 0.76
LDL5 + 6 42.1 ± 7.3 −1.2 ± 2.3 42.1 ± 11.7 8.6 ± 6.8 47.0 ± 7.0 2.6 ± 3.4 0.04 0.29
HDL-C (mg/dl)
Total 43.8 ± 3.7 1.0 ± 2.0 50.8 ± 5.4 1.0 ± 3.0 48.5 ± 2.5 1.0 ± 1.3 0.72 0.88
HDL1 + 2 16.4 ± 3.4 0.6 ± 1.4 21.6 ± 3.2 −0.8 ± 1.7 20.8 ± 2.4 1.0 ± 1.0 0.09 0.49
HDL3 + 4 27.7 ± 1.7 0.4 ± 0.8 29.7 ± 2.3 1.6 ± 1.8 28.1 ± 1.8 0.1 ± 1.0 0.36 0.73
LDL-C:HDL-C
ratio
2.7 ± 0.3 −0.2 ± 0.1 2.6 ± 0.4 0.3 ± 0.2 2.5 ± 0.2 −0.2 ± 0.1 0.0007 0.72
ApoB:ApoA1
ratio
0.7 ± 0.1 −0.1 ± 0.0 0.7 ± 0.1 0.0 ± 0.0 0.7 ± 0.1 0.0 ± 0.0 0.009 0.96
aAll values are means ± SEMs. Statistical differences between groups are based on linear mixed models with baseline values as covariates and adjustments for
age, BMI and change in body fat. Pairwise comparisons were made using post hoc t-test on the linear mixed model with p-values adjusted for multiplicity.
Abbreviations: Apo apolipoprotein, CHO carbohydrate control, HDL-C high density lipoprotein cholesterol, IDL-C intermediate density lipoprotein cholesterol, IDL-P
intermediate density lipoprotein particle number, LDL-C low density lipoprotein cholesterol, LDL-P low density lipoprotein particle number, RED reduced-fat
cheese, REG regular-fat cheese, VLDL-C very low density lipoprotein cholesterol, VLDL-P very low density lipoprotein particle number
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in particle number or HDL composition. In men, no
significant differences were observed in HDL-C after the
REG diet compared to the CHO diet. But, HDL-C in the
larger HDL particles tended to be higher following the REG
diet compared with the RED diet (P = 0.09). Whereas small,
dense LDL particles have been associated with higher inci-
dence of CVD and diabetes, the relation between HDL sub-
fractions and CVD outcomes are more controversial. Large
HDL particles have been suggested to be more cardio pro-
tective than small HDL particles [28–30], although not con-
sistently [31, 32].
Despite the relatively large amount of intervention stud-
ies investigating the effects of cheese intake on the
standard lipid profile compared with other dairy products
[33–37], evidence regarding the effect of cheese on LDL
particle size and lipoprotein subclasses remains scarce. In
fact, the present study is to our knowledge the first
randomized controlled feeding trial to evaluate the cardio-
metabolic effects of cheese intake beyond the standard
lipid profile (TC, LDL-C and HDL-C). However, a few
studies have investigated the impact of other dairy foods
on LDL particle size [38–41]. In 35 healthy men and
women (> 27 kg/m2) the impact on LDL particle size of
low-fat dairy (500 mL low-fat milk and 150 g low-fat
yogurt) was compared with carbohydrate-rich foods
(600 mL fruit juice and 3 fruit biscuits). The low-fat dairy
did not alter LDL or HDL particle number compared with
the carbohydrate diet [39]. In 14 normolipidemic men and
women, the intake of 500 ml/d nonfat milk, but not
whole-fat milk, was associated with larger LDL particles
during a 2 wk. intervention [40]. In a 6-wk randomized,
crossover study, in which 27 postmenstrual women con-
sumed a diet with 3.2 servings/day of 2% fat milk or a milk
and dairy free diet, no differences was observed on LDL
particle size [38]. In healthy men, consumption of full-fat
dairy (milk, butter, and cheese) and dairy products
enriched with naturally derived trans fatty acids was not
associated with changes in LDL particle size [41]. Lastly,
consumption of high-fat dairy diet for 3 wk. did not alter
LDL particle size, whereas consumption of low-fat dairy
reduced LDL particle size compared with a control diet
[25]. The results from these studies suggest that the effect
of dairy on LDL particle size differs in regard to type of
dairy product consumed, metabolic status of the popula-
tion, and gender. Thus, more studies are needed to fully
elucidate the impact of cheese and other dairy products
on LDL particle size distribution.
The strength of the current study was its long
duration, as it increased our ability to detect changes in
lipoprotein profile over a longer time span. The inclu-
sion of a 2-wk run-in period with dietary restrictions
(non-dairy restriction) is also strength as it allowed the
subjects to physically adapt to the dietary changes and
thereby help adjust for prior dietary habits. The fact that
subjects maintained stable body weight throughout the
intervention is an advantage, which (together with the
statistical adjustment for individual changes in body
weight) supports, that our results were independent of
changes in body weight. Limitations of the present study
include the fact that no power calculation was used; thus
a potential risk of reporting false negatives. Compliance
in this study was based on self-reporting, thus a poten-
tial risk of response bias is present. Also, the lack of
biomarkers for assessment of dietary compliance is a
limitation in this study. Lastly, because of the small sam-
ple size, especially in men, generalizability of the study
Table 6 Average daily consumption of energy and macronutrients for the REG, RED and CHO diet during the 12 weeks
interventiona
REG (n = 27) RED (n = 25) CHO (n = 27) PREGvs.RED PREGvs.CHO
Total energy (kJ) 9150 ± 356 8593 ± 557 7973 ± 437 0.56 0.08
Energy density (kcal/g) 1.0 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 0.44 0.70
Fat (% of energy) 36.2 ± 1.3 33.5 ± 0.8 30.0 ± 1.3 0.12 < 0.001
Fat (g) 90.7 ± 5.6 77.5 ± 5.5 65.6 ± 4.6 0.11 < 0.001
Saturated fat (g) 33.3 ± 1.7 27.2 ± 1.7 19.0 ± 1.4 < 0.01 < 0.001
Monounsaturated fat (g) 31.0 ± 2.5 27.1 ± 2.2 24.6 ± 2.1 0.21 < 0.01
Polyunsaturated fat (g) 13.3 ± 1.2 12.7 ± 1.1 13.8 ± 1.2 0.71 0.99
Carbohydrate (% of energy) 40.2 ± 1.6 43.0 ± 1.1 49.7 ± 1.6 0.20 < 0.001
Dietary Fiber (g/d) 23.9 ± 1.3 22.0 ± 1.5 23.4 ± 2.6 0.44 0.85
Protein (% of energy) 19.4 ± 0.8 20.1 ± 0.8 18.3 ± 0.7 0.50 0.20
Alcohol (g) 12.1 ± 2.1 11.0 ± 2.1 5.8 ± 1.7 0.70 0.08
Calcium (mg) 1226 ± 44 1300 ± 53 677 ± 41 0.60 < 0.001
aAll values are means ± SEMs, n = 79 because 6 (subjects had dietary records considered nonsufficient and were therefore removed from the model). Data were
assessed by using 3-d weighted dietary record estimated using Dankost 3000 dietary assessment software (Dankost). Statistical differences were based on linear
mixed models with values for average daily consumption at week 0 for all variables included as covariates. Pairwise comparisons were based on post hoc t- test
with p-values adjusted for multiplicity. Abbreviations: CHO carbohydrate control, RED reduced-fat cheese, REG regular-fat cheese
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results is limited and further research is therefore
needed to determine the effect of regular-fat cheese on
LDL particle size distribution.
Conclusions
In conclusion, regular-fat cheese did not alter overall
LDL particle size distribution compared to reduced-fat
cheese after a 12 wk. intervention in subjects with MetS.
However, our results suggest that lipoprotein response
to cheese intake is gender-specific. This warrants further
investigation.
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